Treatment and prevention of tissue damage
US7615543B2 · kind B2 · utility
0Cited by
5References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 14, 2003 |
| Grant date | Nov 10, 2009 |
| Priority date | — |
| Expiry date | Feb 25, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An agent for use in medicine, which agent comprises a plurality of ligands covalently co-linked so as to form a complex with a plurality of C-reactive protein (CRP) molecules in the presence thereof, wherein (i) at least two of the ligands are the same or different and are capable of being bound by ligand binding sites present on the CRP molecules; or (ii) at least one of the ligands is capable of being bound by a ligand binding site present on a CRP molecule, and at least one other of the ligands is capable of being bound by a ligand binding site present on a serum amyloid P component (SAP) molecule.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.